Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/1998
05/26/1998US5756102 Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
05/26/1998US5756090 Oxygen activatable formulations for disinfection or sterilization
05/26/1998US5756084 Human stromal derived factor 1α and 1β
05/25/1998CA2215929A1 Novel lep
05/22/1998WO1998021338A1 Synthesis and purification of hepatitis c virus-like particles
05/22/1998WO1998021337A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
05/22/1998WO1998021332A2 Secreted proteins and polynucleotides encoding them
05/22/1998WO1998021330A1 Exodus chemokine materials and methods
05/22/1998WO1998021243A1 Method and novel compounds for use therein
05/22/1998WO1998021233A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
05/22/1998WO1998021231A2 Streptococcus uberis lactoferrin-binding protein
05/22/1998WO1998021223A1 Nucleosides
05/22/1998WO1998021222A2 1-galactose derivatives
05/22/1998WO1998021221A2 1-thiogalactose derivatives
05/22/1998WO1998021220A2 Saccharide derivatives
05/22/1998WO1998021218A1 Solid support matrices containing a toxin binding oligosaccharide
05/22/1998WO1998021213A2 2r,4s,r,s- and 2s,4r,r,s-hydroxyitraconazole- and hydroxysaperconazole derivatives
05/22/1998WO1998021212A1 Process for the preparation of salts and esters of clavulanic acid
05/22/1998WO1998021210A1 Tricyclic carbapenem compounds
05/22/1998WO1998021205A1 2r,4s,r,r- and 2s,4r,r,r-hydroxyitraconazole
05/22/1998WO1998021204A1 2r,4s,s,s- and 2s,4r,s,s-hydroxyitraconazole
05/22/1998WO1998021203A1 2r,4s,s,r- and 2s,4r,s,r-hydroxyitraconazole
05/22/1998WO1998021202A1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
05/22/1998WO1998020879A1 L-β-DIOXOLANE URIDINE ANALOGS AND METHODS FOR TREATING AND PREVENTING VIRUS INFECTIONS
05/22/1998WO1998020874A1 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom
05/22/1998WO1998020872A1 Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections
05/22/1998WO1998020868A1 Guanylhydrazones useful for treating diseases associated with t cell activation
05/22/1998WO1998020852A1 Pharmaceutical compositions containing kukui nut oil
05/22/1998WO1998020836A2 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
05/22/1998CA2272404A1 L-.beta.-dioxolane uridine analogs and methods for treating and preventing virus infections
05/22/1998CA2271847A1 Process for the preparation of salts and esters of clavulanic acid
05/22/1998CA2271843A1 Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections
05/22/1998CA2271784A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
05/22/1998CA2271737A1 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom
05/22/1998CA2271732A1 Tricyclic carbapenem compounds
05/22/1998CA2271299A1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
05/22/1998CA2271135A1 Nucleosides
05/22/1998CA2270873A1 Secreted proteins and polynucleotides encoding them
05/22/1998CA2270404A1 Streptococcus uberis lactoferrin-binding protein
05/22/1998CA2269636A1 C3 binding protein of streptococcus pneumoniae
05/22/1998CA2269622A1 2r,4s,r,r- and 2s,4r,r,r-hydroxyitraconazole
05/22/1998CA2269617A1 2r,4s,r,s- and 2s,4r,r,s-hydroxyitraconazole- and hydroxysaperconazole derivatives
05/22/1998CA2269616A1 2r,4s,s,r- and 2s,4r,s,r-hydroxyitraconazole
05/22/1998CA2269608A1 2r,4s,s,s- and 2s,4r,s,s-hydroxyitraconazole
05/22/1998CA2256692A1 Saccharide derivatives
05/22/1998CA2256674A1 1-galactose derivatives
05/22/1998CA2256019A1 Solid support matrices containing a toxin binding oligosaccharide
05/22/1998CA2256016A1 1-thiogalactose derivatives
05/22/1998CA2242384A1 Exodus chemokine materials and methods
05/22/1998CA2242335A1 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
05/21/1998CA2216616A1 Cayae1
05/20/1998EP0843016A2 Staphylococcus FabD (malonylCoA:ACP transacylase) protein
05/20/1998EP0843014A2 Tryptophanyl tRNA synthetase
05/20/1998EP0843011A2 RsbU-1 derived from Staphylococcus
05/20/1998EP0842947A2 Hepatitis C virus asialoglycoproteins
05/20/1998EP0842665A2 Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
05/20/1998EP0842660A1 Composition for treating condyloma acuminata
05/20/1998EP0842428A1 Process for producing gm2 specific antibodies
05/20/1998EP0842297A1 Methods of predicting the outcome of infection
05/20/1998EP0842284A1 Recombinant protein having bacteriophage endosialidase enzymatic activity
05/20/1998EP0842282A1 Alfa-beta c4bp-type recombinant heteromultimeric proteins
05/20/1998EP0842277A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis
05/20/1998EP0842276A1 Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
05/20/1998EP0842192A2 Antimicrobial cationic peptides
05/20/1998EP0842191A2 Cyclosporin derivatives with anti-hiv activity
05/20/1998EP0842186A1 Cross-linking oligonucleotides
05/20/1998EP0842180A1 Novel penam sulfones as beta-lactamase inhibitors
05/20/1998EP0841951A2 Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
05/20/1998EP0841941A1 Novel non-pyrogenic bacterial strains and use of the same
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/20/1998EP0841927A1 Quinolones and their therapeutic use
05/20/1998EP0841921A2 Use of fluconazole for inhibiting the growth of cancers
05/20/1998EP0841919A1 Inhibitors of farnesyl-protein transferase
05/20/1998EP0841914A2 Use of griseofulvin for inhibiting the growth of cancers
05/20/1998EP0841904A1 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors
05/20/1998EP0841903A1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
05/20/1998EP0745083B1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
05/20/1998EP0651806B1 Anti-feline immunodeficiency virus (fiv) vaccines
05/20/1998EP0546076B1 Use of anti-ICAM antibodies in the manufacture of a medicament FOR TREATING ENDOTOXIN SHOCK
05/20/1998EP0383799B1 Adheson variants
05/20/1998CN1182454A DNA molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
05/20/1998CN1182430A Carbohydrate conjugated bio-active compounds
05/20/1998CN1182420A New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for preparation thereof and compositions containing the same as active ingredients
05/20/1998CN1182370A Vaccines containing saponin and sterol
05/20/1998CN1182369A Pharmaceutical compositions for controlled release of soluble receptors
05/20/1998CN1182090A 9 -N -ethenyl derivatives of 9 (S) -erythromycylamine
05/19/1998US5753704 Therapeutic compositions comprising unsaturated dioic acids or derivatives thereof
05/19/1998US5753684 By inhibiting the uptake of urea by macrophages and its conversion to urea
05/19/1998US5753669 Bactericides
05/19/1998US5753666 Quinolones and their therapeutic use
05/19/1998US5753660 Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
05/19/1998US5753629 Amino acid derivative antibiotics; viricides
05/19/1998US5753624 Materials and methods for treatment of plaquing disease
05/19/1998US5753622 Use of epidermal growth factor as a gastrointestinal therapeutic agent
05/19/1998US5753620 Antagonist to tumor necrosis factor and interleukins
05/19/1998US5753503 Capable of selectively binding to gp41 of envelope protein of human immunodeficiency virus type 1
05/19/1998US5753480 Cysteinyl tRNA synthetase polynucleotides of streptococcus
05/19/1998US5753479 Genetic enginnering
05/19/1998US5753476 Identification of a human cytomegalovirus gene region involved in down regulation of MHC class I heavy chain expression
05/19/1998US5753269 Containing silver sulfadiazine
1 ... 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 ... 1798